Published in Diabetes Res Clin Pract on November 06, 2009
Lifestyle Strategies for Improving Diabetes Outcomes | NCT02210845
Effect of Acute Fructose Load in Human | NCT03157960
Dose Response of Eccentric Exercise on Glycemic Control in Type II Diabetes Mellitus | NCT04790526
The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol (2011) 8.15
Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care (2012) 7.83
Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr (2010) 7.70
Fruit and vegetable intake and incidence of type 2 diabetes mellitus: systematic review and meta-analysis. BMJ (2010) 6.05
The worldwide epidemiology of type 2 diabetes mellitus--present and future perspectives. Nat Rev Endocrinol (2011) 5.55
Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Sci Transl Med (2011) 3.84
Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci. Nat Genet (2011) 3.46
Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies. BMJ (2011) 3.36
Risk models and scores for type 2 diabetes: systematic review. BMJ (2011) 3.02
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J (2011) 3.00
The global epidemiology of hepatocellular carcinoma: present and future. Clin Liver Dis (2011) 2.96
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76
Bariatric surgery: an IDF statement for obese Type 2 diabetes. Diabet Med (2011) 2.74
Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study. Diabetologia (2011) 2.43
Kidney disease and increased mortality risk in type 2 diabetes. J Am Soc Nephrol (2013) 2.28
Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent mice. Nat Med (2016) 2.15
Endoplasmic reticulum stress and type 2 diabetes. Annu Rev Biochem (2012) 2.10
Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the joslin 50-year medalist study. Diabetes Care (2011) 2.00
Is it time to revisit the Pedersen hypothesis in the face of the obesity epidemic? Am J Obstet Gynecol (2011) 1.95
Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study. Diabetologia (2011) 1.94
In vivo assessment of bone quality in postmenopausal women with type 2 diabetes. J Bone Miner Res (2014) 1.90
Management of diabetes and associated cardiovascular risk factors in seven countries: a comparison of data from national health examination surveys. Bull World Health Organ (2010) 1.84
Sharing data for public health research by members of an international online diabetes social network. PLoS One (2011) 1.80
Diabetes mellitus type 2 and other chronic non-communicable diseases in the central region, Saudi Arabia (Riyadh cohort 2): a decade of an epidemic. BMC Med (2011) 1.76
Coplanar polychlorinated biphenyls impair glucose homeostasis in lean C57BL/6 mice and mitigate beneficial effects of weight loss on glucose homeostasis in obese mice. Environ Health Perspect (2012) 1.73
Understanding and addressing unique needs of diabetes in Asian Americans, native Hawaiians, and Pacific Islanders. Diabetes Care (2012) 1.72
Association between longer therapy with thiazolidinediones and risk of bladder cancer: a cohort study. J Natl Cancer Inst (2012) 1.69
Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey. Drug Des Devel Ther (2011) 1.68
Spinal cord injury and type 2 diabetes: results from a population health survey. Neurology (2013) 1.62
Long working hours, socioeconomic status, and the risk of incident type 2 diabetes: a meta-analysis of published and unpublished data from 222 120 individuals. Lancet Diabetes Endocrinol (2014) 1.61
Glucose biosensors: an overview of use in clinical practice. Sensors (Basel) (2010) 1.61
Hemoglobin A1c as a screen for previously undiagnosed prediabetes and diabetes in an acute-care setting. Diabetes Care (2011) 1.60
Factors influencing the use of a Web-based application for supporting the self-care of patients with type 2 diabetes: a longitudinal study. J Med Internet Res (2011) 1.58
Prevalence of hypertension, obesity, diabetes, and metabolic syndrome in Nepal. Int J Hypertens (2011) 1.54
Parp inhibition prevents ten-eleven translocase enzyme activation and hyperglycemia-induced DNA demethylation. Diabetes (2014) 1.52
Genetic determinants of hepatic steatosis in man. J Lipid Res (2011) 1.52
A population-based survey of prevalence of diabetes and correlates in an urban slum community in Nairobi, Kenya. BMC Public Health (2013) 1.51
Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability. Clin Liver Dis (2015) 1.51
Fish consumption, dietary long-chain n-3 fatty acids, and risk of type 2 diabetes: systematic review and meta-analysis of prospective studies. Diabetes Care (2012) 1.50
The kidney in type 2 diabetes therapy. Rev Diabet Stud (2011) 1.50
Diabetic mice display a delayed adaptive immune response to Mycobacterium tuberculosis. J Immunol (2010) 1.48
Prevalence of chronic complications of type 2 diabetes mellitus in outpatients - a cross-sectional hospital based survey in urban China. Health Qual Life Outcomes (2010) 1.47
Fruit and vegetable intake and type 2 diabetes: EPIC-InterAct prospective study and meta-analysis. Eur J Clin Nutr (2012) 1.46
Forum for Injection Technique (FIT), India: The Indian recommendations 2.0, for best practice in Insulin Injection Technique, 2015. Indian J Endocrinol Metab (2015) 1.44
Fibroblast growth factor 2 dimer with superagonist in vitro activity improves granulation tissue formation during wound healing. Biomaterials (2015) 1.41
Social but safe? Quality and safety of diabetes-related online social networks. J Am Med Inform Assoc (2011) 1.40
Modulation of hippocampal gene expression of microRNA-146a/microRNA-155-nuclear factor-kappa B inflammatory signaling by troxerutin in healthy and diabetic rats. Indian J Pharmacol (2017) 1.39
Managing diabetes with nanomedicine: challenges and opportunities. Nat Rev Drug Discov (2014) 1.39
Prevalence and risk factors associated with nutrition-related noncommunicable diseases in the Eastern Mediterranean region. Int J Gen Med (2012) 1.39
The health system and population health implications of large-scale diabetes screening in India: a microsimulation model of alternative approaches. PLoS Med (2015) 1.38
Using Automated HbA1c Testing to Detect Diabetes Mellitus in Orthopedic Inpatients and Its Effect on Outcomes. PLoS One (2017) 1.38
Prevalence and Risk Factors for Diabetic Lower Limb Amputation: A Clinic-Based Case Control Study. J Diabetes Res (2016) 1.38
A controlled trial of CPAP therapy on metabolic control in individuals with impaired glucose tolerance and sleep apnea. Sleep (2012) 1.37
Endoplasmic reticulum stress: its role in disease and novel prospects for therapy. Scientifica (Cairo) (2012) 1.37
Diabetic retinopathy and inflammation: novel therapeutic targets. Middle East Afr J Ophthalmol (2012) 1.35
Treating type 2 diabetes mellitus with traditional chinese and Indian medicinal herbs. Evid Based Complement Alternat Med (2013) 1.34
Randomized, placebo-controlled, double-blind glycemic control trial of novel sodium-dependent glucose cotransporter 2 inhibitor ipragliflozin in Japanese patients with type 2 diabetes mellitus. J Diabetes Investig (2013) 1.34
Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol (2014) 1.33
Diabetes mellitus is an independent risk factor for colorectal cancer. Dig Dis Sci (2012) 1.32
Role of microRNAs in diabetes and its cardiovascular complications. Cardiovasc Res (2011) 1.30
Type 2 diabetes: an epidemic requiring global attention and urgent action. Diabetes Care (2012) 1.29
Insulin resistance and truncal obesity as important determinants of the greater incidence of diabetes in Indian Asians and African Caribbeans compared with Europeans: the Southall And Brent REvisited (SABRE) cohort. Diabetes Care (2012) 1.29
Long-term fine particulate matter exposure and mortality from diabetes in Canada. Diabetes Care (2013) 1.29
Diabetic nephropathy and extracellular matrix. J Histochem Cytochem (2012) 1.28
Combined lifestyle factors and cardiovascular disease mortality in Chinese men and women: the Singapore Chinese health study. Circulation (2011) 1.26
Prevalence and risk factors for self-reported diabetes among adult men and women in India: findings from a national cross-sectional survey. Public Health Nutr (2011) 1.26
Smartphone Medical Applications for Women's Health: What Is the Evidence-Base and Feedback? Int J Telemed Appl (2013) 1.26
Neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects. Diabetes (2012) 1.25
Contribution of common genetic variation to the risk of type 2 diabetes in the Mexican Mestizo population. Diabetes (2012) 1.24
Prevalence and management of diabetes and metabolic risk factors in Thai adults: the Thai National Health Examination Survey IV, 2009. Diabetes Care (2011) 1.21
Nutrigenetics and metabolic disease: current status and implications for personalised nutrition. Nutrients (2013) 1.20
Green tea powder and Lactobacillus plantarum affect gut microbiota, lipid metabolism and inflammation in high-fat fed C57BL/6J mice. Nutr Metab (Lond) (2012) 1.20
Diabetes mellitus and its correlates in an Iranian adult population. PLoS One (2011) 1.19
Forecasting the burden of type 2 diabetes in Singapore using a demographic epidemiological model of Singapore. BMJ Open Diabetes Res Care (2014) 1.18
Medicine: diabetes in India. Nature (2011) 1.18
The effects of free-living interval-walking training on glycemic control, body composition, and physical fitness in type 2 diabetic patients: a randomized, controlled trial. Diabetes Care (2012) 1.18
Health-care seeking behaviour among persons with diabetes in Uganda: an interview study. BMC Int Health Hum Rights (2011) 1.18
'I call it the blame and shame disease': a qualitative study about perceptions of social stigma surrounding type 2 diabetes. BMJ Open (2013) 1.17
Perfusion-decellularized pancreas as a natural 3D scaffold for pancreatic tissue and whole organ engineering. Biomaterials (2013) 1.16
Herbal therapies for type 2 diabetes mellitus: chemistry, biology, and potential application of selected plants and compounds. Evid Based Complement Alternat Med (2013) 1.16
Fruit and vegetable intake and risk of type 2 diabetes mellitus: meta-analysis of prospective cohort studies. BMJ Open (2014) 1.16
Understanding the high prevalence of diabetes in U.S. south Asians compared with four racial/ethnic groups: the MASALA and MESA studies. Diabetes Care (2014) 1.16
Circulating levels of TNF-α are associated with impaired glucose tolerance, increased insulin resistance, and ethnicity: the Insulin Resistance Atherosclerosis Study. J Clin Endocrinol Metab (2012) 1.15
Passive smoking and risk of type 2 diabetes: a meta-analysis of prospective cohort studies. PLoS One (2013) 1.15
Hyperglycemia predicts persistently lower muscle strength with aging. Diabetes Care (2014) 1.15
Lifestyle Modification in the Prevention of Type II Diabetes Mellitus. Oman Med J (2012) 1.14
National programme on prevention and control of diabetes in India: Need to focus. Australas Med J (2012) 1.13
Diabetes and weight in comparative studies of bariatric surgery vs conventional medical therapy: a systematic review and meta-analysis. Obes Surg (2014) 1.12
Platelet function in patients with diabetes mellitus: from a theoretical to a practical perspective. Int J Endocrinol (2011) 1.12
Ileal interposition with sleeve gastrectomy for treatment of type 2 diabetes mellitus. Indian J Endocrinol Metab (2012) 1.12
Type 2 diabetes in Xinjiang Uygur autonomous region, China. PLoS One (2012) 1.12
Increasing prevalence of type 2 diabetes in Chinese adults in Shanghai. Diabetes Care (2012) 1.12
Limb regeneration is impaired in an adult zebrafish model of diabetes mellitus. Wound Repair Regen (2010) 1.12
Curcumin alleviates diabetic cardiomyopathy in experimental diabetic rats. PLoS One (2012) 1.11
Diabetic retinopathy in sub-Saharan Africa: meeting the challenges of an emerging epidemic. BMC Med (2013) 1.11
Inadequate diabetic care: global figures cry for preventive measures and personalized treatment. EPMA J (2010) 1.10
Diabetes buddies: peer support through a mobile phone buddy system. Diabetes Educ (2012) 1.10
Marine N-3 polyunsaturated fatty acids are inversely associated with risk of type 2 diabetes in Asians: a systematic review and meta-analysis. PLoS One (2012) 1.10
Influence of patients' disease knowledge and beliefs about medicines on medication adherence: findings from a cross-sectional survey among patients with type 2 diabetes mellitus in Palestine. BMC Public Health (2014) 1.10
Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med (1998) 46.95
Television viewing time and mortality: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Circulation (2010) 7.03
Waist circumference, waist-hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults. J Intern Med (2003) 3.39
Associations of TV viewing and physical activity with the metabolic syndrome in Australian adults. Diabetologia (2005) 3.02
Decline in incidence of epidemic glucose intolerance in Nauruans: implications for the "thrifty genotype". Am J Epidemiol (1991) 2.61
Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius? Diabetes Care (1999) 2.41
The Evaluation of Screening and Early Detection Strategies for Type 2 Diabetes and Impaired Glucose Tolerance (DETECT-2) update of the Finnish diabetes risk score for prediction of incident type 2 diabetes. Diabetologia (2010) 2.33
Determining diabetes prevalence: a rational basis for the use of fasting plasma glucose concentrations? Diabet Med (1990) 2.16
Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes (1993) 2.15
High prevalence of NIDDM and impaired glucose tolerance in Indian, Creole, and Chinese Mauritians. Mauritius Noncommunicable Disease Study Group. Diabetes (1990) 2.01
Continuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study. Diabetologia (2009) 1.85
Independent and opposite associations of waist and hip circumferences with diabetes, hypertension and dyslipidemia: the AusDiab Study. Int J Obes Relat Metab Disord (2004) 1.78
Occupational status and cardiovascular disease risk factors in the rapidly developing, high-risk population of Mauritius. Am J Epidemiol (1998) 1.75
Lifetime risk and projected population prevalence of diabetes. Diabetologia (2008) 1.73
Foot complications in Type 2 diabetes: an Australian population-based study. Diabet Med (2003) 1.58
Low-dose growth hormone replacement lowers plasma leptin and fat stores without affecting body mass index in adults with growth hormone deficiency. Clin Endocrinol (Oxf) (1996) 1.45
Blood pressure studies in rural and urban Western Samoa. Med J Aust (1980) 1.41
New classification and criteria for diagnosis of diabetes mellitus. The Australasian Working Party on Diagnostic Criteria for Diabetes Mellitus. N Z Med J (1999) 1.37
The epidemiology of obesity. Baillieres Clin Endocrinol Metab (1994) 1.37
Gender differences in the prevalence of impaired fasting glycaemia and impaired glucose tolerance in Mauritius. Does sex matter? Diabet Med (2003) 1.36
Relationship between prevalence of impaired glucose tolerance and NIDDM in a population. Diabetes Care (1991) 1.34
Type 2 diabetes worldwide according to the new classification and criteria. Diabetes Care (2000) 1.33
Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality. Diabetologia (1999) 1.33
Dramatic increase in the prevalence of obesity in western Samoa over the 13 year period 1978-1991. Int J Obes Relat Metab Disord (1994) 1.32
GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush diabetes. Diabetes (1994) 1.30
Prevalence of diabetic retinopathy in Type 2 diabetes in developing and developed countries. Diabet Med (2013) 1.25
Impaired fasting glucose: how low should it go? Diabetes Care (2000) 1.24
Acid production in diabetic acidosis; a more rational approach to alkali replacement. Br Med J (1970) 1.22
Current controversies in the use of haemoglobin A1c. J Intern Med (2012) 1.20
Impact of new diagnostic criteria for diabetes on different populations. Diabetes Care (1999) 1.17
The metabolic syndrome as a tool for predicting future diabetes: the AusDiab study. J Intern Med (2008) 1.16
Increasing prevalence of NIDDM in the Pacific island population of Western Samoa over a 13-year period. Diabetes Care (1994) 1.16
Health behaviours, socioeconomic status and diabetes incidence: the Australian Diabetes Obesity and Lifestyle Study (AusDiab). Diabetologia (2010) 1.16
Differences in height explain gender differences in the response to the oral glucose tolerance test- the AusDiab study. Diabet Med (2008) 1.13
Plasma insulin response among Nauruans. Prediction of deterioration in glucose tolerance over 6 yr. Diabetes (1987) 1.12
Prevalence and risk factors for diabetic retinopathy in the multiethnic population of Mauritius. Am J Epidemiol (1998) 1.12
Diagnostic thresholds for diabetes: the association of retinopathy and albuminuria with glycaemia. Diabetes Res Clin Pract (2006) 1.11
Abdominal obesity and physical inactivity as risk factors for NIDDM and impaired glucose tolerance in Indian, Creole, and Chinese Mauritians. Diabetes Care (1991) 1.10
Serum insulin distributions and reproducibility of the relationship between 2-hour insulin and plasma glucose levels in Asian Indian, Creole, and Chinese Mauritians. Mauritius NCD Study Group. Metabolism (1993) 1.09
A bi-directional relationship between obesity and health-related quality of life: evidence from the longitudinal AusDiab study. Int J Obes (Lond) (2011) 1.08
Improved endothelial function following a 14-month resistance exercise training program in adults with type 2 diabetes. Diabetes Res Clin Pract (2007) 1.07
The prevention of type 2 diabetes--lifestyle change or pharmacotherapy? A challenge for the 21st century. Diabetes Res Clin Pract (2003) 1.06
Antibodies to glutamic acid decarboxylase discriminate major types of diabetes mellitus. Diabetes (1992) 1.06
The inverse relationship between number of steps per day and obesity in a population-based sample: the AusDiab study. Int J Obes (Lond) (2006) 1.06
The relationship of retinal vascular calibre to diabetes and retinopathy: the Australian Diabetes, Obesity and Lifestyle (AusDiab) study. Diabetologia (2007) 1.05
Metabolism and blood levels of angiotensin II in normal subjects, renal disease, and essential hypertension. Circ Res (1970) 1.05
Acute and chronic effects of exercise on leptin levels in humans. J Appl Physiol (1985) (1997) 1.04
Association of physical activity and serum insulin concentrations in two populations at high risk for type 2 diabetes but differing by BMI. Diabetes Care (2001) 1.03
Should we dump the metabolic syndrome? No. BMJ (2008) 1.03
Angiotensin II blood-levels in human hypertension. Lancet (1971) 1.02
Antibodies to diabetes-associated autoantigens in Indian patients with Type 1 diabetes: prevalence of anti-ICA512/IA2 and anti-SOX13. Diabetes Res Clin Pract (2001) 1.00
Anti-glutamate decarboxylase and other antibodies at the onset of childhood IDDM: a population-based study. Diabetologia (1994) 0.99
Physical inactivity and glucose intolerance in the multiethnic island of Mauritius. Med Sci Sports Exerc (1995) 0.98
High prevalence of diabetic retinopathy and nephropathy in Polynesians of Western Samoa. Diabetes Care (1995) 0.98
Extraordinary prevalence of non-insulin-dependent diabetes mellitus and bimodal plasma glucose distribution in the Wanigela people of Papua New Guinea. Med J Aust (1994) 0.97
High prevalence of hyperuricaemia and gout in an urbanised Micronesian population. Br Med J (1978) 0.97
The metabolic syndrome: in need of a global mission statement. Diabet Med (2009) 0.97
The metabolic syndrome as a predictor of incident diabetes mellitus in Mauritius. Diabet Med (2007) 0.96
Abnormal glucose tolerance and alcohol consumption in three populations at high risk of non-insulin-dependent diabetes mellitus. Am J Epidemiol (1993) 0.96
Features of the metabolic syndrome predict higher risk of diabetes and impaired glucose tolerance: a prospective study in Mauritius. Diabetes Care (2000) 0.95
HOMA insulin sensitivity index and the risk of all-cause mortality and cardiovascular disease events in the general population: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab) study. Diabetologia (2009) 0.95
Modernity and obesity in coastal and Highland Papua New Guinea. Int J Obes Relat Metab Disord (1995) 0.95
New diagnostic criteria and classification of diabetes--again? Diabet Med (1998) 0.94
Metabolic and immunologic features of Chinese patients with atypical diabetes mellitus. Diabetes Care (2000) 0.94
The prevalence of diabetes mellitus in a traditional-living Polynesian population: the Wallis Island survey. Diabetes Care (1983) 0.93
Evidence against association between parity and NIDDM from five population groups. Diabetes Care (1991) 0.93
Determinants of estimated insulin resistance and beta-cell function in Indian, Creole and Chinese Mauritians. The Mauritius NCD Study Group. Diabetes Res Clin Pract (1991) 0.93
The association of modernization with dyslipidaemia and changes in lipid levels in the Polynesian population of Western Samoa. Int J Epidemiol (1997) 0.93
Higher leptin levels in Asian Indians than Creoles and Europids: a potential explanation for increased metabolic risk. Int J Obes (Lond) (2010) 0.92
Characterization of obesity phenotypes in Psammomys obesus (Israeli sand rats). Int J Exp Diabetes Res (2000) 0.92
Diabetes and nontraumatic lower extremity amputations. Incidence, risk factors, and prevention--a 12-year follow-up study in Nauru. Diabetes Care (1996) 0.90
Abdominal fat distribution and insulin levels only partially explain adverse cardiovascular risk profile in Asian Indians. J Cardiovasc Risk (1996) 0.90
High mortality from cardiovascular disease and analysis of risk factors in Indian and Melanesian Fijians. Int J Epidemiol (1996) 0.90
Leptin and other components of the Metabolic Syndrome in Mauritius--a factor analysis. Int J Obes Relat Metab Disord (2001) 0.90
Non-insulin-dependent diabetes and 11-year mortality in Asian Indian and Melanesian Fijians. Diabet Med (1996) 0.89
Incidence, increasing prevalence, and predictors of change in obesity and fat distribution over 5 years in the rapidly developing population of Mauritius. Int J Obes Relat Metab Disord (1996) 0.89
Obesity, hypertension, carbohydrate disorders and the risk of chronic diseases. Is there any epidemiological evidence for integrated prevention programmes? Med J Aust (1986) 0.89
Diabetic neuropathy in Mauritius: prevalence and risk factors. Diabetes Res Clin Pract (1998) 0.88
Diurnal variation in glucose tolerance: associated changes in plasma insulin, growth hormone, and non-esterified fatty acids. Br Med J (1974) 0.87
Beacon: a novel gene involved in the regulation of energy balance. Diabetes (2000) 0.87
Incidence of IDDM in Mauritian children and adolescents from 1986 to 1990. Diabetes Care (1993) 0.85
Antibodies to pancreatic islet cell antigens in diabetes seen in Southern India with particular reference to fibrocalculous pancreatic diabetes. Diabet Med (1998) 0.85
Prevalence and secular trends in obesity in Pacific and Indian Ocean island populations. Obes Res (1995) 0.85
Combination of polymorphisms in OB-R and the OB gene associated with insulin resistance in Nauruan males. Int J Obes Relat Metab Disord (1999) 0.85
Does abnormal insulin action or insulin secretion explain the increase in prevalence of impaired glucose metabolism with age in populations of different ethnicities? Diabetes Metab Res Rev (2010) 0.84
Association between hyperglycaemia and fracture risk in non-diabetic middle-aged and older Australians: a national, population-based prospective study (AusDiab). Osteoporos Int (2010) 0.84
Maximizing efficiency and cost-effectiveness of Type 2 diabetes screening: the AusDiab study. Diabet Med (2011) 0.84
Epidemiology of type II diabetes: an international perspective. Pharmacoeconomics (1995) 0.83
Two-hour glucose predicts the development of hypertension over 5 years: the AusDiab study. J Hum Hypertens (2007) 0.83
Relationship of insulin resistance to weight gain in nondiabetic Asian Indian, Creole, and Chinese Mauritians. Mauritius Non-communicable Disease Study Group. Metabolism (1996) 0.83
Is leptin sensitivity the link between smoking cessation and weight gain? Int J Obes Relat Metab Disord (1997) 0.83
Prevalence and risk factors for micro- and macroalbuminuria in diabetic subjects and entire population of Nauru. Diabetes (1989) 0.83
Evaluation of ICA512As in combination with other islet cell autoantibodies at the onset of IDDM. Diabetes Care (1997) 0.83
Comparing incident diabetes as defined by fasting plasma glucose or by HbA(1c). The AusDiab, Inter99 and DESIR studies. Diabet Med (2011) 0.82
Weight change amongst Nauruans over 6.5 years: extent, and association with glucose intolerance. Diabetes Res Clin Pract (1987) 0.82
Association of body mass index and waist-hip circumference ratio with cardiovascular disease risk factors in Micronesian Nauruans. Int J Obes Relat Metab Disord (1993) 0.82
A genetic marker at the glucokinase gene locus for type 2 (non-insulin-dependent) diabetes mellitus in Mauritian Creoles. Diabetologia (1992) 0.81
Serum lipids and modernization in coastal and highland Papua New Guinea. Am J Epidemiol (1996) 0.81